Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Roma Nikhat"'
Autor:
Zameer Shervani, Roma Nikhat, Sadia Hasan, Nudrat Jamal, Kehkeshan Fatma, Umair Yaqub Qazi, Venkata Phani Sai Reddy Vuyyuru, Adil Ahmed Khan, Parangimalai Diwakar Madan Kumar, Muhammad Jehanzeb Khan, Aisha Mahmood, Rabiya Khan
Publikováno v:
European Journal of Medical and Health Sciences. 5:41-48
Salient findings of the fourth serological survey of SARS-CoV-2 infections conducted among the age cohort above 10 years in Tamil Nadu (India) have been described. The overall seroprevalence of 87% was reported in the survey done in December 2021, wh
Autor:
Zameer Shervani, Roma Nikhat, Sadia Hasan, Umair Yaqub Qazi, Kehkeshan Fatma, Arif Siddiquie, Venkata Phani Sai Reddy Vuyyuru, Nudrat Jamal, Aiman Ibbrahim, Samar Siddiqui, Adil Ahmed Khan, Parangimalai Diwakar Madan Kumar, Manseej Purang, Ankira Agarwal
Publikováno v:
European Journal of Medical and Health Sciences. 4:12-16
The breakthrough infections (BTI) during the Delta wave in the general population have been investigated. The BTI reported in the city of Gurugram (Haryana, India) in the month of August, September, and October 2021 were studied. The monthly BTI in A
Autor:
Zameer Shervani, Deepali Bhardwaj, Roma Nikhat, Aiman Ibbrahim, Sadia Hasan, Intazam Khan, Umair Yaqub Qazi, Adil Ahmed Khan, Kehkeshan Fatma, Yamin Siddiqui, Ankira Agarwal, Samar Siddiqui, Shazma Khan, Abdullah Sherwani
Publikováno v:
European Journal of Medical and Health Sciences. 4:27-32
The seroprevalence in Indian states Haryana and Odisha has been investigated. The seropositivity in the Haryana population increased with time from 8% to 14.8% to 76.3% as recorded in August, October 2020, and September 2021, respectively. The virus
Autor:
Zameer Shervani, Deepali Bhardwaj, Roma Nikhat, Aiman Ibbrahim, Intazam Khan, Sadia Hasan, Umair Yaqub Qazi, Ankira Agarwal, Adil Ahmed Khan, Abdullah Sherwani
Publikováno v:
European Journal of Medical and Health Sciences. 4:61-66
The results of all six serosurveys of Delhi (India) have been analysed. The first serosurvey held in June-July 2020 found seroprevalence in 22.9% population. The second, third, and fourth survey conducted in August, September, and October registered
Autor:
Zameer Shervani, Deepali Bhardwaj, Roma Nikhat, Aiman Ibbrahim, Intazam Khan, Umair Yaqub Qazi, Ankira Agarwal, Adil Ahmed Khan, Sadia Hasan, Abdullah Sherwani
Publikováno v:
European Journal of Medical and Health Sciences. 4:27-32
The results of the fourth COVID-19 national serosurvey (June-July 2021) of India have been analysed. Much needed data of vaccine generated antibodies have been reported world first as recorded in Indian population on the ground in real. More than two
Publikováno v:
European Journal of Medical and Health Sciences. 3:95-99
The self-referred serosurvey data showed that the whole of India, 31% population has SARS-CoV-2 antibodies. Seroprevalence was higher in females (35%) than males (30%). The seropositivity in Ahmedabad, Jaipur, Bangalore, and Delhi increased monotonou
Publikováno v:
European Journal of Medical and Health Sciences. 3:38-41
The first and second serosurvey results of COVID-19 antibodies in Dharavi and Cuffe Parade slums (Mumbai, India) were studied. The seroprevalence data of the slums explained the zero novel coronavirus cases reported in the slum dwellers verified firs